Cover Image
Market Research Report
Product code 
1092239

AI In Medical Imaging Market - Global Outlook & Forecast 2022-2027

Published: | Arizton Advisory & Intelligence | 335 Pages | Delivery time: 1-2 business days

Price

Back to Top
AI In Medical Imaging Market - Global Outlook & Forecast 2022-2027
Published: June 20, 2022
Arizton Advisory & Intelligence
Content info: 335 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The global AI in medical imaging market is expected to grow at a CAGR of 45.68% during the forecast period 2022-2027.

The constant increase in the number of diagnostic procedures and the decline in the number of radiologists, increasing work pressure on the radiologists, have increased the need for artificial intelligence adoption in the medical imaging space. The researchers are looking for multiple ways to implement artificial intelligence into medical imaging. The demand for artificial intelligence is constantly increasing in the medical imaging software market. From cardiac events, neurological conditions, fractures, or thoracic complications, artificial intelligence helps physicians to diagnose and provide treatment quickly. Implementing AI in medical imaging has enhanced medical screening, improved precision medicine software, reduced physicians' load, etc.

Technological Advancements Revolutionizing AI in Medical Imaging

  • There have been many technological advancements in AI-based medical imaging technologies, which have shown their increasing acceptance in high-income countries. Some of the improvements include the development of integrated rtiI software, which can directly be integrated into imaging equipment (MRI or CT scanner) which facilitates the automation of medical image analysis. Other advances include smartphone technology integration in AI in medical imaging in which front-line health workers could non-invasively screen for various conditions by leveraging a smartphone.
  • AI in medical imaging has drawn the attention of several radiologists worldwide. It gives faster and more accurate results and reduces diagnostic errors at reduced costs compared to traditional medical imaging methods. Thus, radiologists believe that AI in medical imaging may bring an enormous opportunity for its increasing implementation in the upcoming years.
  • In recent years, many large established companies, such as GE Healthcare and Siemens Healthineers, have enabled themselves to grow the AI in the medical imaging market by making huge investments for increasing partnerships and acquisitions. Other large healthcare-related or software companies not previously invested in health care, such as Thermo Fisher Scientific and Paraxel, have started making huge investments in the market.

Vendor's Activity in AI-Based Medical Imaging Market

Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips, and IBM Watson Health are the major players in the global AI in the medical imaging market. International players focus on developing innovative products with advanced technologies and expanding their product portfolio to remain competitive. They are continuously investing extensively in R&D to expand their product portfolio. Manufacturers such as GE Healthcare constantly focus on introducing new products with innovative technology platforms opening the platform (Edison Developer Program) for other companies offering artificial intelligence technologies to scale and deploy their developed applications across GE Healthcare's customer base.

Many major players are engaged in strategic acquisitions and partnerships that continue to be a competitive strategy for the key players, thus helping them grow inorganically. Innovative product approvals coupled with R&D activities are also helping the vendors to expand their presence, enhance growth, and sustain their position in the global market. In 2021, more than 30 countries approved AI in medical imaging technologies that are FDA and CE approved.

There is increasing funding and investments by public and private entities, including large companies, which is also one of the major driving factors of AI in the medical imaging market. For instance, more than 20 start-ups from various regions have received funds to develop AI-based medical imaging technologies.

GEOGRAPHY INSIGHTS

  • North America holds a dominant position in artificial intelligence in the medical imaging market. High adoption of advanced technologies is the primary factor for its larger industry share. In addition, the strong presence of the key players in the region is also a contributor to North America for holding a high market share.
  • Europe is the second-largest market for AI-based medical imaging. The presence of prominent market players and high healthcare spending are the primary factors for the significant market share in this region. The industry in Europe is mainly driven by the increasing collaborative research with extensive funding from the government. Increasing funding and investments are also driving the AI-based medical imaging market in the region.
  • The adoption rate of advanced artificial intelligence technologies in the medical imaging sector is still emerging in the Asia-pacific region. In recent years, there has been a noticeable investment and funding made by government and corporations and increasing collaborations and partnerships among the companies, research centers, and institutes. Due to these factors, the industry is growing exponentially in this region.
  • Lack of awareness of the importance of artificial intelligence in medical imaging, radiologists' job insecurity, a lack of sufficient IT infrastructure, a lack of proper training and knowledge among radiologists, concerns about data security, and a shortage of skilled professionals are all factors contributing to the industry's slow growth in Latin America, the Middle East, and Africa.
  • Among all the regions, APAC could witness the highest growth over the forecast period, with a CAGR of 51.06% in the global industry. The increasing prevalence of chronic diseases and diagnostic errors has opened enormous opportunities for APAC medical imaging AI market growth.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East And Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

SEGMENTATION ANALYSIS

Hospitals are purchasing the artificial intelligence medical software suits as a complete package for the usage or taking up one program at a time which is used the most in the industry. The diagnostic imaging center's significant revenue generation is through imaging procedures, and they are primarily involved in implementing advanced products, which will attract customers. For instance, AI in medical imaging, along with clinical data, is helping physicians to predict heart attacks in patients accurately.

Neurology has accounted for the dominating share in the industry. The majority of the initial artificial intelligence product development focuses on downstream processing. This Downstream processing majorly includes artificial intelligence for segmentation, detecting anatomical structures, and quantifying a range of pathologies. Conditions like intracranial hemorrhage, ischemic stroke, primary brain tumors, cerebral metastases, and abnormal white matter signal intensities, which were unmet needs in the industry, has become commercially available solution within the radiology industry.

AI in medical imaging, especially cardiovascular magnetic resonance (CMR), is revolutionized by providing deep learning solutions, especially for image acquisitions, reconstructions, and analysis, which helps in supporting clinical decision-making. CMR is an established tool for routine clinical decision-making, including diagnosis, follow-up, real-time procedures, and pre-procedure planning.

Deep learning methods have enabled more tremendous success in medical image analysis. They have helped high accuracy, efficiency, stability, and scalability. Artificial intelligence tools have become assistive tools in medicine with benefits like error reduction, accuracy, fast computing, and better diagnostics. Natural language processing, Computer Vision, and Context-Aware Computing technologies are also used to create new analysis methods for medical imaging products.

In 2021, Philips showcased its new AI-enabled CT imaging portfolio. Their new CT 5100 with smart workflow application applies artificial intelligence at every step of CT image processing.

Siemens Healthineers's AI-Rad companion chest CT detects and highlights lung nodules. The tumor burden is automatically calculated.

In addition, AI-Rad companion chest X-Ray played a significant role in patient management during the COVID-19 pandemic. The artificial intelligence-Rad companion file automatically processes upright chest X-ray images, pneumothorax, nodule detection, etc. This indicates the consolidations and atelectasis. This indicates the sign of pneumonia caused by the COVID-19 virus.

Artificial intelligence in CT scans and MRI dominated the industry, as much medical imaging using artificial intelligence tools falls into these modality categories. However, artificial intelligence in ultrasound and detecting mammography is largely adopted in the industry.

Segmentation by Technology

  • Deep Learning
  • NIP
  • Others

Segmentation by Application

  • Neurology
  • Respiratory & Pulmonary
  • Cardiology
  • Breast Screening
  • Orthopedic
  • Others

Segmentation by Modalities

  • CT
  • MRI
  • X-RAY
  • Ultrasound
  • Nuclear Imaging

Segmentation by End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Key Vendors

  • General Electric
  • Siemens Healthineers
  • Koninklijke Philips
  • IBM Watson Health

Other Prominent Vendors

  • Agfa-Gevaert Group/Agfa HealthCare
  • Arterys
  • Avicenna.AI
  • AZmed
  • Butterfly Network
  • Caption Health
  • CellmatiQ
  • dentalXrai
  • Digital Diagnostics
  • EchoNous
  • GLEAMER
  • HeartVista
  • iCAD
  • Lunit
  • Mediaire
  • MEDO
  • Nanox Imaging
  • Paige AI
  • Perimeter Medical Imaging AI
  • Predible Health
  • 1QB Information Technology
  • Qure.ai
  • Quantib
  • QLARITY IMAGING
  • Quibim
  • Renalytix
  • Therapixel
  • Ultromics
  • Viz.ai
  • VUNO

KEY QUESTIONS ANSWERED

  • 1. How Big is the Artificial Intelligence in Medical Imaging Market?
  • 2. What is the Growth Rate of the AI in Medical Imaging Market?
  • 3. Who are is the Key Players in the AI in Medical Imaging Market?
  • 4. What are is the Latest Trends in the AI-Based Medical Imaging Market?
  • 5. Which Region Is Expected to hold the largest share in the AI-Based Medical Imaging Market?
Product Code: Sample_AI-Based Medical Imaging Market - Global Outlook & Forecast 2022-2027_Arizton.pdf

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET BY TECHNOLOGY
    • 4.3.2 MARKET BY APPLICATION
    • 4.3.3 MARKET BY MODALITY
    • 4.3.4 MARKET BY END USER
    • 4.3.5 MARKET BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 BACKGROUND
  • 7.2 ARTIFICIAL INTELLIGENCE IN HEALTHCARE INDUSTRY
  • 7.3 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING
  • 8.2 INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES
  • 8.3 GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING

9 MARKET GROWTH ENABLERS

  • 9.1 RISE IN NUMBER OF DIAGNOSTIC PROCEDURES
  • 9.2 EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING
  • 9.3 RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS
  • 9.4 DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS

10 MARKET RESTRAINTS

  • 10.1 LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS
  • 10.2 LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING
  • 10.3 CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
    • 11.2.1 INSIGHTS BY TECHNOLOGY
    • 11.2.2 INSIGHTS BY APPLICATION
    • 11.2.3 INSIGHTS BY MODALITY
    • 11.2.4 INSIGHTS BY END USER
  • 11.3 FIVE FORCES ANALYSIS
    • 11.3.1 THREAT OF NEW ENTRANTS
    • 11.3.2 BARGAINING POWER OF SUPPLIERS
    • 11.3.3 BARGAINING POWER OF BUYERS
    • 11.3.4 THREAT OF SUBSTITUTES
    • 11.3.5 COMPETITIVE RIVALRY

12 TECHNOLOGY

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 DEEP LEARNING
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 MARKET BY GEOGRAPHY
  • 12.4 NLP
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 MARKET BY GEOGRAPHY
  • 12.5 OTHERS
    • 12.5.1 MARKET OVERVIEW
    • 12.5.2 MARKET SIZE & FORECAST
    • 12.5.3 MARKET BY GEOGRAPHY

13 APPLICATION

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 NEUROLOGY
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 RESPIRATORY & PULMONARY
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 CARDIOLOGY
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 BREAST CANCER
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 ORTHOPEDIC
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY
  • 13.8 OTHERS
    • 13.8.1 MARKET OVERVIEW
    • 13.8.2 MARKET SIZE & FORECAST
    • 13.8.3 MARKET BY GEOGRAPHY

14 MODALITY

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 CT
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 MRI
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 X-RAY
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 ULTRASOUND
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY
  • 14.7 NUCLEAR IMAGING
    • 14.7.1 MARKET OVERVIEW
    • 14.7.2 MARKET SIZE & FORECAST
    • 14.7.3 MARKET BY GEOGRAPHY

15 END USER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 HOSPITALS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 DIAGNOSTIC IMAGING CENTERS
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 OTHERS
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 NORTH AMERICA: TECHNOLOGY SEGMENTATION
  • 17.4 NORTH AMERICA: APPLICATION SEGMENTATION
  • 17.5 NORTH AMERICA: MODALITY SEGMENTATION
  • 17.6 NORTH AMERICA: END-USER SEGMENTATION
  • 17.7 KEY COUNTRIES
    • 17.7.1 US: MARKET SIZE & FORECAST
    • 17.7.2 CANADA MARKET SIZE & FORECAST

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 EUROPE: TECHNOLOGY SEGMENTATION
  • 18.4 EUROPE: APPLICATION SEGMENTATION
  • 18.5 EUROPE: MODALITY SEGMENTATION
  • 18.6 EUROPE: END-USER SEGMENTATION
  • 18.7 KEY COUNTRIES
    • 18.7.1 GERMANY: MARKET SIZE & FORECAST
    • 18.7.2 UK: MARKET SIZE & FORECAST
    • 18.7.3 FRANCE: MARKET SIZE & FORECAST
    • 18.7.4 ITALY: MARKET SIZE & FORECAST
    • 18.7.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 APAC: TECHNOLOGY SEGMENTATION
  • 19.4 APAC: APPLICATION SEGMENTATION
  • 19.5 APAC: MODALITY SEGMENTATION
  • 19.6 APAC: END-USER SEGMENTATION
  • 19.7 KEY COUNTRIES
    • 19.7.1 CHINA: MARKET SIZE & FORECAST
    • 19.7.2 INDIA: MARKET SIZE & FORECAST
    • 19.7.3 JAPAN: MARKET SIZE & FORECAST
    • 19.7.4 AUSTRALIA: MARKET SIZE & FORECAST
    • 19.7.5 SOUTH KOREA: MARKET SIZE & FORECAST

20 LATIN AMERICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 LATIN AMERICA: TECHNOLOGY SEGMENTATION
  • 20.4 LATIN AMERICA: APPLICATION SEGMENTATION
  • 20.5 LATIN AMERICA: MODALITIES SEGMENTATION
  • 20.6 LATIN AMERICA: END-USER SEGMENTATION
  • 20.7 KEY COUNTRIES
    • 20.7.1 BRAZIL: MARKET SIZE & FORECAST
    • 20.7.2 MEXICO: MARKET SIZE & FORECAST
    • 20.7.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION
  • 21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
  • 21.5 MIDDLE EAST & AFRICA: MODALITIES SEGMENTATION
  • 21.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
  • 21.7 KEY COUNTRIES
    • 21.7.1 TURKEY: MARKET SIZE & FORECAST
    • 21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 21.7.3 UAE: MARKET SIZE & FORECAST
    • 21.7.4 SOUTH AFRICA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 MARKET SHARE ANALYSIS
    • 22.2.1 GENERAL ELECTRIC
    • 22.2.2 SIEMENS HEALTHINEERS
    • 22.2.3 KONINKLIJKE PHILIPS
    • 22.2.4 IBM WATSON HEALTH

23 KEY COMPANY PROFILES

  • 23.1 GENERAL ELECTRIC
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
    • 23.1.3 KEY STRATEGIES
    • 23.1.4 KEY STRENGTHS
    • 23.1.5 KEY OPPORTUNITIES
  • 23.2 SIEMENS HEALTHINEERS
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
    • 23.2.3 KEY STRATEGIES
    • 23.2.4 KEY STRENGTHS
    • 23.2.5 KEY OPPORTUNITIES
  • 23.3 KONINKLIJKE PHILIPS
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
    • 23.3.3 KEY STRATEGIES
    • 23.3.4 KEY STRENGTHS
    • 23.3.5 KEY OPPORTUNITIES
  • 23.4 IBM WATSON HEALTH
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 PRODUCT OFFERINGS
    • 23.4.3 KEY STRATEGIES
    • 23.4.4 KEY STRENGTHS
    • 23.4.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 AGFA-GEVAERT GROUP
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
  • 24.2 ARTERYS
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 AVICENNA.AI
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
  • 24.4 AZMED
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERINGS
  • 24.5 BUTTERFLY NETWORK
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 CAPTION HEALTH
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 PRODUCT OFFERINGS
  • 24.7 CELLMATIQ
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 PRODUCT OFFERINGS
  • 24.8 DENTALXRAI
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 PRODUCT OFFERINGS
  • 24.9 DIGITAL DIAGNOSTICS
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 PRODUCT OFFERINGS
  • 24.10 ECHONOUS
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 PRODUCT OFFERINGS
  • 24.11 GLEAMER
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 PRODUCT OFFERINGS
  • 24.12 HEARTVISTA
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 PRODUCT OFFERINGS
  • 24.13 ICAD
    • 24.13.1 BUSINESS OVERVIEW
    • 24.13.2 PRODUCT OFFERINGS
  • 24.14 LUNIT
    • 24.14.1 BUSINESS OVERVIEW
    • 24.14.2 PRODUCT OFFERINGS
  • 24.15 MEDIAIRE
    • 24.15.1 BUSINESS OVERVIEW
    • 24.15.2 PRODUCT OFFERINGS
  • 24.16 MEDO
    • 24.16.1 BUSINESS OVERVIEW
    • 24.16.2 PRODUCT OFFERINGS
  • 24.17 NANOX IMAGING
    • 24.17.1 BUSINESS OVERVIEW
    • 24.17.2 PRODUCT OFFERINGS
  • 24.18 PAIGE AI
    • 24.18.1 BUSINESS OVERVIEW
    • 24.18.2 PRODUCT OFFERINGS
  • 24.19 PERIMETER MEDICAL IMAGING AI
    • 24.19.1 BUSINESS OVERVIEW
    • 24.19.2 PRODUCT OFFERINGS
  • 24.20 PREDIBLE HEALTH
    • 24.20.1 BUSINESS OVERVIEW
    • 24.20.2 PRODUCT OFFERINGS
  • 24.21 1QB INFORMATION TECHNOLOGIES
    • 24.21.1 BUSINESS OVERVIEW
    • 24.21.2 PRODUCT OFFERINGS
  • 24.22 QURI.AI
    • 24.22.1 BUSINESS OVERVIEW
    • 24.22.2 PRODUCT OFFERINGS
  • 24.23 QUANTIB
    • 24.23.1 BUSINESS OVERVIEW
    • 24.23.2 PRODUCT OFFERINGS
  • 24.24 QLARITY IMAGING
    • 24.24.1 BUSINESS OVERVIEW
    • 24.24.2 PRODUCT OFFERINGS
  • 24.25 QUIBIM
    • 24.25.1 BUSINESS OVERVIEW
    • 24.25.2 PRODUCT OFFERINGS
  • 24.26 RENALYTIX
    • 24.26.1 BUSINESS OVERVIEW
    • 24.26.2 PRODUCT OFFERINGS
  • 24.27 THERAPIXEL
    • 24.27.1 BUSINESS OVERVIEW
    • 24.27.2 PRODUCT OFFERINGS
  • 24.28 ULTROMICS
    • 24.28.1 BUSINESS OVERVIEW
    • 24.28.2 PRODUCT OFFERINGS
  • 24.29 VIZ.AI
    • 24.29.1 BUSINESS OVERVIEW
    • 24.29.2 PRODUCT OFFERINGS
  • 24.30 VUNO
    • 24.30.1 BUSINESS OVERVIEW
    • 24.30.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 MARKET BY GEOGRAPHY
  • 26.2 MARKET BY TECHNOLOGY
  • 26.3 MARKET BY APPLICATION
  • 26.4 MARKET BY MODALITY
  • 26.5 MARKET BY END USER
  • 26.6 NORTH AMERICA BY TECHNOLOGY
  • 26.7 NORTH AMERICA BY APPLICATION
  • 26.8 NORTH AMERICA BY MODALITY
  • 26.9 NORTH AMERICA BY END USER
  • 26.10 EUROPE BY TECHNOLOGY
  • 26.11 EUROPE BY APPLICATION
  • 26.12 EUROPE BY MODALITY
  • 26.13 EUROPE BY END USER
  • 26.14 APAC BY TECHNOLOGY
  • 26.15 APAC BY APPLICATION
  • 26.16 APAC BY MODALITY
  • 26.17 APAC BY END USER
  • 26.18 LATIN AMERICA BY TECHNOLOGY
  • 26.19 LATIN AMERICA BY APPLICATION
  • 26.20 LATIN AMERICA BY MODALITY
  • 26.21 LATIN AMERICA BY END USER
  • 26.22 MIDDLE EAST AND AFRICA BY TECHNOLOGY
  • 26.23 MIDDLE EAST AND AFRICA BY APPLICATION
  • 26.24 MIDDLE EAST AND AFRICA BY MODALITY
  • 26.25 MIDDLE EAST AND AFRICA BY END USER

27 APPENDIX

  • 27.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL AI-BASED MEDICAL IMAGING MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
  • EXHIBIT 3 SECTORS CONTRIBUTING TO DEVELOPMENT OF HEALTHCARE IT
  • EXHIBIT 4 SCOPE OF AI IN MEDICAL IMAGING
  • EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING
  • EXHIBIT 6 IMPACT OF INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES
  • EXHIBIT 7 PERCENTAGE OF IMAGING CENTERS AND HOSPITALS IMPLEMENTING AI-BASED MEDICAL IMAGING DEVICES IN US 2019
  • EXHIBIT 8 IMPACT OF GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING
  • EXHIBIT 9 IMPACT OF RISE IN NUMBER OF DIAGNOSTIC PROCEDURES
  • EXHIBIT 10 GROWTH IN IMAGING ACTIVITY 2014/15 & 2018/19 (%)
  • EXHIBIT 11 DIAGNOSTIC PROCEDURES/TECHNIQUES USED IN AI STUDIES
  • EXHIBIT 12 IMPACT OF EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING
  • EXHIBIT 13 IMPACT OF RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS
  • EXHIBIT 14 IMPACT OF DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS
  • EXHIBIT 15 IMPACT OF LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS
  • EXHIBIT 16 IMPACT OF LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING
  • EXHIBIT 17 IMPACT OF CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING
  • EXHIBIT 18 GLOBAL AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 19 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021 & 2027 (%)
  • EXHIBIT 20 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021 & 2027 (%)
  • EXHIBIT 21 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021 & 2027 (%)
  • EXHIBIT 22 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END-USER 2021 & 2027 (%)
  • EXHIBIT 23 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 24 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 25 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY
  • EXHIBIT 26 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 27 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: ABSOLUTE GROWTH (%)
  • EXHIBIT 28 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING - INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 29 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING 2021-2027 ($ MILLION)
  • EXHIBIT 30 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 31 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP 2021-2027 ($ MILLION)
  • EXHIBIT 32 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 33 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 34 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 35 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES 2021-2027 ($ MILLION)
  • EXHIBIT 36 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 37 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 38 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION
  • EXHIBIT 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
  • EXHIBIT 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY 2021-2027 ($ MILLION)
  • EXHIBIT 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY 2021-2027 ($ MILLION)
  • EXHIBIT 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY AND PULMONARY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY 2021-2027 ($ MILLION)
  • EXHIBIT 49 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 50 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 51 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING 2021-2027 ($ MILLION)
  • EXHIBIT 52 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 53 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 MOST STUDIED ORTHOPEDIC AREAS FOR AI-BASED IMAGE INTERPRETATION (%)
  • EXHIBIT 55 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC 2021-2027 ($ MILLION)
  • EXHIBIT 56 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 57 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 58 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS 2021-2027 ($ MILLION)
  • EXHIBIT 59 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 60 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
  • EXHIBIT 61 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY
  • EXHIBIT 62 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 63 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: ABSOLUTE GROWTH (%)
  • EXHIBIT 64 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT 2021-2027 ($ MILLION)
  • EXHIBIT 65 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 66 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 67 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 68 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI 2021-2027 ($ MILLION)
  • EXHIBIT 69 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 70 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 71 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY 2021-2027 ($ MILLION)
  • EXHIBIT 72 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 73 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 74 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND 2021-2027 ($ MILLION)
  • EXHIBIT 75 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 76 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING 2021-2027 ($ MILLION)
  • EXHIBIT 77 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 78 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 80 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER
  • EXHIBIT 81 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 82 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: ABSOLUTE GROWTH (%)
  • EXHIBIT 83 PERCENTAGE OF ANNUAL EXAMINATIONS PER RADIOLOGY DEPARTMENT IN US
  • EXHIBIT 84 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 85 DIAGNOSTIC ERRORS IN DIFFERENT AREAS IN FINLAND (%)
  • EXHIBIT 86 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS 2021-2027 ($ MILLION)
  • EXHIBIT 87 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 88 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTER: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 89 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS 2021-2027 ($ MILLION)
  • EXHIBIT 90 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 91 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 92 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS 2021-2027 ($ MILLION)
  • EXHIBIT 93 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 94 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 95 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY
  • EXHIBIT 96 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 97 GLOBAL AI-BASED MEDICAL IMAGING BY GEOGRAPHY: ABSOLUTE GROWTH (%)
  • EXHIBIT 98 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 99 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
  • EXHIBIT 100 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 101 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 103 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
  • EXHIBIT 104 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 105 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 106 US AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 107 CANADA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 108 EUROPE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 109 EUROPE AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 110 EUROPE AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021($ MILLION)
  • EXHIBIT 111 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 112 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 113 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
  • EXHIBIT 114 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 115 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 116 GERMANY AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 117 UK AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 118 FRANCE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 119 MEDICAL IMAGING ACTIVITIES IN ITALY (%)
  • EXHIBIT 120 ITALY AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 121 SPAIN AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 122 APAC AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 123 APAC AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
  • EXHIBIT 124 APAC AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 125 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 126 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 127 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
  • EXHIBIT 128 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 129 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 130 CHINA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 131 AI-BASED MEDICAL IMAGING MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 132 JAPAN AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 133 AUSTRALIA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 134 AI-BASED MEDICAL IMAGING MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 135 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 136 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
  • EXHIBIT 137 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 138 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 139 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 140 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027
  • EXHIBIT 141 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 142 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 143 BRAZIL AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 144 MEXICO AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 145 ARGENTINA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 146 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 147 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
  • EXHIBIT 148 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 149 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 150 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 151 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027
  • EXHIBIT 152 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 153 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 154 AI-BASED MEDICAL IMAGING MARKET IN TURKEY 2021-2027 ($ MILLION)
  • EXHIBIT 155 SAUDI ARABIA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 156 UAE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 157 SOUTH AFRICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 158 PURE & DIVERSIFIED COMPANIES IN GLOBAL AI-BASED MEDICAL IMAGING MARKET
  • EXHIBIT 159 GLOBAL AI-BASED MEDICAL IMAGING MARKET: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 160 VENDORS IN GLOBAL AI-BASED MEDICAL IMAGING MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 161 GENERAL ELECTRIC: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 162 GENERAL ELECTRIC: TOTAL REVENUE BY HEALTHCARE SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 163 GENERAL ELECTRIC: R&D EXPENDITURE IN HEALTHCARE SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 164 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 165 SIEMENS HEALTHINEERS: TOTAL REVENUE BY IMAGING SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 166 KONINKLIJKE PHILIPS: REVENUE BY DIAGNOSIS AND TREATMENT BUSINESS 2019-2021 ($ MILLION)
  • EXHIBIT 167 KONINKLIJKE PHILIPS: R&D EXPENDITURE IN DIAGNOSIS AND TREATMENT BUSINESS SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 168 IBM: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 169 IBM: TOTAL R&D EXPENDITURE ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 START-UPS INVOLVED IN DEVELOPMENT OF AI-BASED MEDICAL IMAGING
  • TABLE 4 LIST OF FDA-APPROVED AI-BASED MEDICAL IMAGING PLATFORMS
  • TABLE 5 GENERAL ELECTRIC: MAJOR PRODUCT OFFERINGS
  • TABLE 6 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
  • TABLE 7 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
  • TABLE 8 IBM: MAJOR PRODUCT OFFERINGS
  • TABLE 9 AGFA-GEVAERT GROUP: MAJOR PRODUCT OFFERINGS
  • TABLE 10 ARTERYS: MAJOR PRODUCT OFFERINGS
  • TABLE 11 AVICENNA.AI: MAJOR PRODUCT OFFERINGS
  • TABLE 12 AZMED: MAJOR PRODUCT OFFERINGS
  • TABLE 13 BUTTERFLY NETWORK: MAJOR PRODUCT OFFERINGS
  • TABLE 14 CAPTION HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 15 CELLMATIQ: MAJOR PRODUCT OFFERINGS
  • TABLE 16 DENTALXRAI: MAJOR PRODUCT OFFERINGS
  • TABLE 17 DIGITAL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 18 ECHONOUS: MAJOR PRODUCT OFFERINGS
  • TABLE 19 GLEAMER: MAJOR PRODUCT OFFERINGS
  • TABLE 20 HEARTVISTA: MAJOR PRODUCT OFFERINGS
  • TABLE 21 ICAD: MAJOR PRODUCT OFFERINGS
  • TABLE 22 LUNIT: MAJOR PRODUCT OFFERINGS
  • TABLE 23 MEDIAIRE: MAJOR PRODUCT OFFERINGS
  • TABLE 24 MEDO: MAJOR PRODUCT OFFERINGS
  • TABLE 25 NANOX IMAGING: MAJOR PRODUCT OFFERINGS
  • TABLE 26 PAIGE AI: MAJOR PRODUCT OFFERINGS
  • TABLE 27 PERIMETER MEDICAL IMAGING AI: MAJOR PRODUCT OFFERINGS
  • TABLE 28 PREDIBLE HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 29 1QB INFORMATION TECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 30 QURE.AI: MAJOR PRODUCT OFFERINGS
  • TABLE 31 QUANTIB: MAJOR PRODUCT OFFERINGS
  • TABLE 32 QLARITY IMAGING: MAJOR PRODUCT OFFERINGS
  • TABLE 33 QUIBIM: MAJOR PRODUCT OFFERINGS
  • TABLE 34 RENALYTIX: MAJOR PRODUCT OFFERINGS
  • TABLE 35 THERAPIXEL: MAJOR PRODUCT OFFERINGS
  • TABLE 36 ULTROMICS: MAJOR PRODUCT OFFERINGS
  • TABLE 37 VIZ.AI: MAJOR PRODUCT OFFERINGS
  • TABLE 38 VUNO: MAJOR PRODUCT OFFERINGS
  • TABLE 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
  • TABLE 49 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 50 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 51 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 52 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 53 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 54 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 55 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 56 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
  • TABLE 57 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 58 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 59 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 60 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 61 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 62 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 63 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 64 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
  • TABLE 65 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 66 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 67 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 68 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 69 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 70 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 71 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 72 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
  • TABLE 73 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 74 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 75 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 76 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 77 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 78 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 79 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 80 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
  • TABLE 81 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
  • TABLE 82 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 83 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 84 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 85 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
  • TABLE 86 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
  • TABLE 87 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
  • TABLE 88 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)